Erasca, Inc. (ERAS) vs Heartflow, Inc. Common Stock (HTFL)

A side-by-side comparison of Erasca, Inc. and Heartflow, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Erasca, Inc. logo
ERAS
Erasca, Inc.
$5.05B
$14.55HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Heartflow, Inc. Common Stock logo
HTFL
Heartflow, Inc. Common Stock
$4.38B
$50.74HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT

Total return — ERAS vs HTFL

growth of $100 · dividends reinvested · last 1y
ERAS +951.4% (+951.4%/yr)HTFL +81.6% (+81.6%/yr)ERAS compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002026$1,051$182
ERAS HTFL

ERAS vs HTFL: by the numbers

  • •ERAS is the larger company ($5.05B vs $4.38B market cap).
  • •Both run net losses; ERAS's is the smaller (0.00% vs -55.82% net margin).

Metrics side by side

Valuation

MetricERASHTFL
P/S ratioN/A20.63
P/B ratio13.9615.64

Profitability

MetricERASHTFL
Gross margin0.00%80.08%
Operating margin0.00%-34.31%
Net margin0.00%-55.82%
ROE-79.37%-42.32%
ROIC-38.03%-23.69%

Growth (annualized)

MetricERASHTFL
Total return CAGR (5Y)-8.34%N/A

Go deeper

Full ERAS analysisFull HTFL analysisInteractive comparison tool

Dig into the metrics

Erasca ROEHeartflow, Inc. Common Stock ROEErasca operating marginHeartflow, Inc. Common Stock operating marginErasca revenue growthHeartflow, Inc. Common Stock revenue growthErasca free cash flowHeartflow, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.